GT Biopharma logo
GT Biopharma GTBP
$ 1.77 -8.03%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

GT Biopharma Operating Income 2011-2024 | GTBP

Annual Operating Income GT Biopharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-13.6 M -21.3 M -57.5 M -6.76 M 16.1 M -250 M -136 M -9.37 M -8.93 M -2.4 M -793 K -3.51 M -3.93 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
16.1 M -250 M -38.3 M

Quarterly Operating Income GT Biopharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-3.6 M -3.91 M -3.09 M - -3.12 M -3.62 M -3.66 M - -7.02 M -3.01 M -5.44 M - -5.95 M -4.38 M -29 M - -1.94 M -1.56 M 1.07 M - -8.86 M -2.28 M -4.06 M - -235 M -5.16 M -7.16 M - -127 M -1.28 M -1.54 M - -2.53 M -2.12 M -3.9 M - -2.78 M -1.43 M -1.81 M - -549 K -104 K -101 K - -140 K -140 K -347 K - -1.35 M -1.03 M -396 K - -541 K -481 K -1.86 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.07 M -235 M -11.7 M